LEADER 01154nam--2200385---450- 001 990000781450203316 005 20050530104913.0 010 $a3-465-02646-2 035 $a0078145 035 $aUSA010078145 035 $a(ALEPH)000078145USA01 035 $a0078145 100 $a20011130d1994----km-y0itay0103----ba 101 $ager 102 $aDE 105 $a||||||||001yy 200 1 $aKants Logik des ästhetischen Urteils$fJens Kulenkampff 210 $aFrankfurt am Main$cV. Klostermann$d1994 215 $a249 p$d24 cm 225 2 $aPhilosophische Abhandlungen$v61 410 $12001$aPhilosophische Abhandlungen$v61 606 0 $aKant, Immanuel$xEstetica 676 $a111.85092 700 1$aKULENKAMPFF,$bJens$0550349 801 0$aIT$bsalbc$gISBD 912 $a990000781450203316 951 $aII.1.C. 397(IV A 1417)$b123745 LM$cIV A 959 $aBK 969 $aUMA 979 $aPATTY$b90$c20011130$lUSA01$h1026 979 $c20020403$lUSA01$h1725 979 $aPATRY$b90$c20040406$lUSA01$h1654 979 $aCOPAT3$b90$c20050530$lUSA01$h1049 996 $aKants Logik des ästhetischen Urteils$9965378 997 $aUNISA LEADER 02791nam 22005772 450 001 9910463543903321 005 20160226161710.0 010 $a1-107-71093-6 010 $a1-107-71435-4 010 $a9786611828264 010 $a1-904752-74-8 010 $a1-281-82826-2 010 $a1-139-69693-9 035 $a(CKB)2670000000560895 035 $a(MiAaPQ)EBC3399993 035 $a(MiAaPQ)EBC4949701 035 $a(Au-PeEL)EBL3399993 035 $a(CaPaEBR)ebr10511558 035 $a(OCoLC)923352915 035 $a(UkCbUP)CR9781139696937 035 $a(Au-PeEL)EBL4949701 035 $a(CaONFJC)MIL182826 035 $a(OCoLC)1024282717 035 $a(EXLCZ)992670000000560895 100 $a20140116d2008|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMenopause for the MRCOG and beyond /$fMargaret Rees$b[electronic resource] 205 $aSecond edition. 210 1$aLondon :$cRCOG Press,$d2008. 215 $a1 online resource (ix, 118 pages) $cdigital, PDF file(s) 225 1 $aMRCOG and beyond series 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a1-904752-44-6 320 $aIncludes bibliographical references and index. 330 $aThis book examines some of the controversies in the management of the menopause and postmenopausal health following publication of the US Women's Health Initiative studies and the UK Million Women Study. It also focuses on how to explain risk to women coping with the menopause and the risks in certain clinical situations. Systemic HRT and non-HRT options for treatment are evaluated, together with diet and lifestyle, alternative and complementary therapies. Conditions associated with the menopause, such as vasomotor symptoms, urogenital and sexual problems, osteoporosis and autoimmune arthritis, breast disease and gynaecological benign and malignant conditions, are covered. The symptoms, diagnosis and treatment of premature menopause, or premature ovarian failure, are detailed, and a section on treating women with concomitant medical problems completes the text. Primarily designed to provide a comprehensive summary for candidates preparing for the Part 2 MRCOG examination, it is also a valuable guide for all healthcare professionals. 410 0$aMRCOG and beyond series. 517 3 $aMenopause for the MRCOG & Beyond 606 $aMenopause 615 0$aMenopause. 676 $a618.175 700 $aRees$b Margaret$g(Margaret C. P.),$0609710 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910463543903321 996 $aMenopause for the MRCOG and beyond$92482651 997 $aUNINA